Amgen’s new drug could be a blockbuster
IN THIS ARTICLE
- Banking & Finance Topic
- Jorge Mercado Author
By Jorge Mercado Friday, June 4th, 2021
An Amgen researcher in lab that developed the new Lumakras cancer treatment (courtesy photo) In 2018, Amgen got its first green light to administer a new drug called sotorasib to people in clinical trials. Just three years later, that drug, now known as Lumakras, has been approved as a cancer treatment by the U.S. Food…